protein degradation

Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
protein degradation
Arvinas
Merck KGaA
Sanofi
Pfizer
Novartis
Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
Investors Business Daily
Wed, 05/29/24 - 09:27 pm
Biohaven
immune disease
protein degradation
BHV-1300
immune disorders
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Fierce Biotech
Thu, 04/11/24 - 11:56 am
Novartis
Arvinas
protein degradation
prostate cancer
Gilead dives deeper into Nurix protein degrader collab, paying $15M for 2-year extension
Fierce Biotech
Tue, 04/2/24 - 11:38 am
Gilead Sciences
Nurix Therapeutics
protein degradation
Firefly Bio assembles with $94M and an ADC dream team to work on protein degraders
Fierce Biotech
Thu, 02/15/24 - 11:23 am
Firefly Bio
protein degradation
Merck offers up to $610M for one of C4’s protein degraders
Fierce Biotech
Tue, 12/12/23 - 11:07 am
Merck
C4 Therapeutics
protein degradation
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
Roche pays $50M upfront to Monte Rosa in molecular glue deal
Fierce Biotech
Tue, 10/17/23 - 09:46 pm
Roche
molecular glue
Monte Rosa
QuEEN
protein degradation
Nurix and Seagen Collaborate on Breakthrough Cancer Therapeutics
Globe Newswire
Thu, 09/7/23 - 10:57 am
Nurix Therapeutics
Seagen
protein degradation
cancer
antibody-drug conjugate
Astellas notches another protein degrader pact with $21M upfront for PeptiDream
Fierce Biotech
Tue, 07/25/23 - 10:08 am
Astellas
protein degradation
PeptiDream
Astellas delves deeper into protein degrading drugs with Cullgen deal
BioPharma Dive
Thu, 06/15/23 - 09:55 am
Astellas
Cullgen
protein degradation
Proxygen, averaging a new collab every 10 months, sticks $2.5B molecular glue deal with Merck
Fierce Biotech
Wed, 04/5/23 - 10:09 am
Merck
Proxygen
molecular glue
protein degradation
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
BioPharma Dive
Wed, 03/22/23 - 10:07 am
Genentech
EpiBiologics
protein degradation
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
Pfizer's $1B protein degradation bet yields 3% response rate in Arvinas' midphase breast cancer trial
Fierce Biotech
Tue, 11/22/22 - 11:00 am
Pfizer
protein degradation
Arvinas
clinical trials
breast cancer
ARV-471
Merck KGaA Strikes $550M Deal with Proxygen in Latest Protein Degradation Deal
BioSpace
Fri, 06/3/22 - 10:29 am
Merck KGaA
Proxygen
protein degradation
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
Yahoo/Accesswire
Tue, 05/10/22 - 10:29 pm
Evotec
Bristol Myers Squibb
protein degradation
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up
Fierce Biotech
Wed, 02/23/22 - 10:34 am
Plexium
Amgen
protein degradation
venture capital
funding
Origami Therapeutics developing treatments for neurodegenerative diseases with ML and computational chemistry
MedCity News
Thu, 11/4/21 - 10:26 am
Origami Therapeutics
protein degradation
neurodegenerative disease
Huntington's disease
Novartis makes protein degrader play, inking deal with new British startup to access fruits of novel tech
Fierce Biotech
Tue, 11/2/21 - 10:53 am
Novartis
protein degradation
Dunad Therapeutics
biobucks

Pages